Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism | PLOS ONE
Principal markers useful for risk stratification in acute pulmonary... | Download Table
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) | European Respiratory Society
Cardiac Biomarkers for Risk Stratification of Patients With Acute Pulmonary Embolism | Circulation
Risk stratification in normotensive acute pulmonary embolism patients: focus on the intermediate–high risk subgroup - Ana Rita Santos, Pedro Freitas, Jorge Ferreira, Afonso Oliveira, Mariana Gonçalves, Daniel Faria, João Bicho Augusto, Joana
PERT Development and Implementation to Standardize Patient Pathway for Pulmonary Embolism - Endovascular Today
Interventional Treatment of Pulmonary Embolism | Circulation: Cardiovascular Interventions
Role of echocardiography in managing acute pulmonary embolism
Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction | European Respiratory Society
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium | Nature Reviews Cardiology
Final Diagnosis -- Case 735
Coronary Embolism: A Systematic Review - ScienceDirect
Pulmonary Embolism: Don't Throw Out That EKG! — NUEM Blog
Frontiers | A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology | JACC: CardioOncology
The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis | Critical Care | Full Text
Risk Stratification in Acute Normotensive Pulmonary Embolism– Role of Echocardiography Imaging and Biomarkers
Medicina | Free Full-Text | Cardiac Biomarkers in Patients with Acute Pulmonary Embolism
treatment of pulmonary embolism - Primary Care Notebook
Heart-type fatty acid binding protein (H-FABP): early marker of acute cardiac syndrome and risk stratification in pulmonary embolism. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.
Cardiac marker - Wikipedia
Cardiac Biomarkers for Risk Stratification of Patients With Acute Pulmonary Embolism | Circulation
Suggested role of echocardiography and biomarkers in the prognostic... | Download Scientific Diagram
Advances in Respiratory Medicine | Free Full-Text | Using a Fibrinolysis Delivery Catheter in Pulmonary Embolism Treatment for Measurement of Pulmonary Artery Hemodynamics
